Abstract
Mitochondria play key roles in a broad range of biomedical situations, consequently there is a need to direct bioactive compounds to mitochondria as both therapies and probes. A successful approach has been to target compounds to mitochondria by conjugation to lipophilic cations, such as triphenylphosphonium (TPP), which utilize the large mitochondrial membrane potential (Δψm, negative inside) to drive accumulation. This has proven effective both in vitro and in vivo for a range of bioactive compounds and probes. However so far only neutral appendages have been targeted to mitochondria in this way. Many bioactive functional moieties that we would like to send to mitochondria contain ionisable groups with pK a in the range that creates an assortment of charged species under physiological conditions. To see if such ionisable compounds can also be taken up by mitochondria, we determined the general requirements for the accumulation within mitochondria of a TPP cation conjugated to a carboxylic acid or an amine. Both were taken up by energised mitochondria in response to the protonmotive force. A lipophilic TPP cation attached to a carboxylic acid was accumulated to a greater extent than a simple TPP cation due to the interaction of the weakly acidic group with the pH gradient (ΔpH). In contrast, a lipophilic TPP cation attached to an amine was accumulated less than the simple cation due to exclusion of the weakly basic group by the ΔpH. From these data we derived a simple equation that describes the uptake of lipophilic cations containing ionisable groups as a function of Δψm, ΔpH and pK a. These findings may facilitate the rational design of additional mitochondrial targeted probes and therapies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Asin-Cayuela J, Manas AR, James AM, Smith RA, Murphy MP (2004) Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 571(1–3):9–16
Azzone GF, Pietrobon D, Zoratti M (1984) Determination of the proton electrochemical gradient across biological membranes. Curr Top Bioenerg 13:1–77
Brand MD (1995) Measurement of mitochondrial protonmotive force. In: Brown GC, Cooper CE (eds) Bioenergetics - a practical approach. IRL, Oxford, pp 39–62
Brown GC, Brand MD (1985) Thermodynamic control of electron flux though mitochondria cytochrome bc 1 complex. Biochem J 225(2):399–405
Chappell JB, Hansford RG (1972) Preparation of mitochondria from animal tissues and yeasts. In: Birnie GD (ed) Subcellular components: preparation and fractionation. Butterworths, London, pp 77–91
Cocheme HM, Quin C, McQuaker SJ, Cabreiro F, Logan A, Prime TA, Abakumova I, Patel JV, Fearnley IM, James AM et al (2011) Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab 13(3):340–350
Dhanasekaran A, Kotamraju S, Karunakaran C, Kalivendi SV, Thomas S, Joseph J, Kalyanaraman B (2005) Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic Biol Med 39(5):567–583
Dickinson BC, Chang CJ (2008) A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc 130(30):9638–9639
Duchen MR, Szabadkai G (2010) Roles of mitochondria in human disease. Essays Biochem 47:115–137
Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, Frampton CM, Taylor KM, Smith RA, Murphy MP (2010) The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 30(7):1019–1026
Gornall AG, Bardawill CJ, David MM (1949) Determination of serum protein by means of the biuret reaction. J Biol Chem 177(2):751–766
Hoerr CW, McCorkle MR, Ralston AW (1943) Studies on the high molecular weoight aliphatic amines and their salts. X. Ioinzation constants of primary and symmetrical secondary amines in aqueous solution. J Am Chem Soc 65(3):328–329
Kanicky JR, Shah DO (2003) Effect of premicellar aggregation on the pK a of fatty acid soap solutions. Langmuir 19:2034–2038
Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276(7):4588–4596
Klayman DL, Grenan MM, Jacobus DP (1969) Potential antiradiation agents. I. Primary aminoalkanethiosulfuric acids. J Med Chem 12(3):510–512
Lopez M, Hardy MJ, Kalyanaraman B, Zhao M (2009) 99mTc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors (USA). Cancer Biother Radiopharm 24(5):579–587
Murphy MP (2009) Mitochondria–a neglected drug target. Curr Opin Investig Drugs 10(10):1022–1024
Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656
Porteous CM, Logan A, Evans C, Ledgerwood EC, Menon DK, Aigbirhio F, Smith RA, Murphy MP (2010) Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochim Biophys Acta 1800(9):1009–1017
Prime TA, Blaikie FH, Evans C, Nadtochiy SM, James AM, Dahm CC, Vitturi DA, Patel RP, Hiley CR, Abakumova I et al (2009) A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci USA 106(26):10764–10769
Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, Murphy MP, Beckman JS (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 103(41):15038–15043
Ross MF, Kelso GF, Blaikie FH, James AM, Cocheme HM, Filipovska A, Da Ros T, Hurd TR, Smith RA, Murphy MP (2005) Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc) 70(2):222–230
Ross MF, Da Ros T, Blaikie FH, Prime TA, Porteous CM, Severina II, Skulachev VP, Kjaergaard HG, Smith RA, Murphy MP (2006) Accumulation of lipophilic dications by mitochondria and cells. Biochem J 400(1):199–208
Smith RA, Murphy MP (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 1201:96–103
Smith RA, Hartley RC, Murphy MP (2011) Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal 15(12):3021–3038
Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O’Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM (2010) A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson’s disease. Mov Disord 25(11):1670–1674
Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297–348
Wube AA, Hufner A, Thomaschitz C, Blunder M, Kollroser M, Bauer R, Bucar F (2011) Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones. Bioorg Med Chem 19(1):567–579
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary materials
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 118 kb)
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Finichiu, P.G., James, A.M., Larsen, L. et al. Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pK a: implications for the design of mitochondrial probes and therapies. J Bioenerg Biomembr 45, 165–173 (2013). https://doi.org/10.1007/s10863-012-9493-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-012-9493-5